Cytomegalovirus glycoprotein B genotypes and central nervous system disease in AIDS patients

Journal of Medical Virology

Volumn 71, Issue 3, 2003, Pages 404-407

  Vilas Boas, Lucy S ^a   De Souza, Vanda A Ueda F ^a   De Oliveira, Augusto C Penalva ^b   Rodriguez Viso, Ana T ^a,b   Nascimento Filho, Anderson M ^a   Nascimento, Maria C ^a   Pannuti, Cláudio S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

AIDS; CNS disease; Cytomegalovirus; gB; Genotypes; PCR

Indexed keywords

GLYCOPROTEIN B; PROTEIN HINFFL; PROTEIN RSAL; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; POLYMERASE CHAIN REACTION; URINALYSIS; VIRUS DETECTION; VIRUS STRAIN;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0141535228     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10488     Document Type: Article

References (38)

1. Aquino VH, Figueiredo LT. 2000. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 61:138-142.
2. Bongarts AD, von Laer D, Vogelberg C, Ebert K, van Lunzen J, Garweg J, Vaith P, Hufert FT, Haller O, Meyer-Konig U. 1996. Glycoprotein B genotype of human cytomegalovirus: Distribution in HIV-infected patients. Scand J Infect Dis 28:447-449.
3. Chern KC, Chandler DB, Martin DF, Kuppermann BD, Wolitz RA, Margolis TP. 1998. Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis 178:1149-1153.
4. Chou SW, Dennison KM. 1991. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163:1229-1234.
5. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. 2003. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77:4588-4596.
6. Fidouh-Houhou N, Duval X, Bissuel F, Bourbonneux V, Flandre P, Ecobichon JL, Jordan MC, Vilde JL, Brun-Vezinet F, Leport C. 2001. Salivary cytomegalovirus (CMV) shedding, glycoprotein b genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis 33:1406-1411.
7. Fries BC, Chou S, Boeckh M, Torok-Storb B. 1994. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 169:769-774.
8. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE, The Zidovudine Epidemiology Study Group. 1992. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 166:1223-1227.
9. Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G. 1999. Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: Lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol 59:98-103.
10. Haberland M, Meyer-Konig U, Hufert FT. 1999. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J Gen Virol 80:1495-1500.
11. Hebart H, Greif M, Krause H, Kanz L, Jahn G, Muller CA, Einsele H. 1997. Interstrain variation of immediate early DNA sequences and glycoprotein B genotypes in cytomegalovirus clinical isolates. Med Microbiol Immunol (Berl) 186:135-138.
12. Kniess N, Mach M, Fay J, Britt WJ. 1991. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. J Virol 65:138-146.
13. Liu YN, Klaus A, Kari B, Stinski MF, Eckhardt J, Gehrz RC. 1991. The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans. J Virol 65:1644-1648.
14. Marshall GS, Rabalais GP, Stout GG, Waldeyer SL. 1992. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J Infect Dis 165:381-384.
15. Meyer-Konig U, Ebert K, Schrage B, Pollak S, Hufert FT. 1998a. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352:1280-1281.
16. Meyer-Konig U, Vogelberg C, Bongarts A, Kampa D, Delbruck R, Wolff-Vorbeck G, Kirste G, Haberland M, Hufert FT, von Laer D. 1998b. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 55:75-81.
17. Monforte AD, Mainini F, Vago L, Magni C, Musicco M, Antinori S, Bini T, Moroni M. 1993. Factors associated with increased risk of acquiring cytomegalovirus disease in AIDS patients. J Infect Dis 168:1071-1072.
18. Monforte AD, Mainini F, Testa L, Vago L, Balotta L, Nebuloni M, Antinori S, Bini T, Moroni M. 1997. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS 11:517-524.
19. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. 1993. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143-158.
20. Numazaki K, Ikehata M, Asanuma H, Chiba S. 1998. Simultaneous infection of immunocompetent individuals with multiple cytomegalovirus strains. Lancet 352:1710.
21. Peek R, Verbraak F, Bruinenberg M, van der Lelij A, van den Horn G, Kijlstra A. 1998. Cytomegalovirus glycoprotein B genotyping in ocular fluids and blood of AIDS patients with cytomegalovirus retinitis. Invest Ophthalmol Vis Sci 39:1183-1187.
22. Pietropaolo RL, Compton T. 1997. Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II. J Virol 71:9803-9807.
23. Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW. 2001. A review of genetic differences between limited and extensive passaged human cytomegalovirus strains. Rev Med Virol 11:191-200.
24. Rasmussen L, Nelson M, Neff M, Merigan TC, Jr. 1988. Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody. Virology 163:308-318.
25. Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, Miner R, Drew WL, Wolitz R, Dowling A, Warford A, Merigan TC. 1997. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 175:179-184.
26. Rasmussen L, Geissler A, Winters M. 2003. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis 187:809-819.
27. Rosen HR, Corless CL, Rabkin J, Chou S. 1998. Association of cytomegalovirus genotype with graft rejection after liver transplantation. Transplantation 66:1627-1631.
28. Schoppel K, Kropff B, Schmidt C, Vornhagen R, Mach M. 1997. The humoral immune response against individual cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J Infect Dis 175:533-544.
29. Schoppel K, Schmidt C, Einsele H, Hebart H, Mach M. 1998. Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients. J Infect Dis 178:1233-1243.
30. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. 1996. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 174:184-187.
31. Speckner A, Glykofrydes D, Ohlin M, Mach M. 1999. Antigenic domain 1 ofhuman cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization. J Gen Virol 80:2183-2191.
32. Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T. 1997. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90:2097-2102.
33. Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pereira L. 1994. Function of human cytomegalovirus glycoprotein B: Syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology 201:263-276.
34. Tugizov S, Wang Y, Qadri I, Navarro D, Maidji E, Pereira L. 1995. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology 209:580-591.
35. Vogelberg C, Meyer-Konig U, Hufert FT, Kirste G, von Laer D. 1996. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 50:31-34.
36. Wada K, Mizuno S, Kato K, Kamiya T, Ozawa K. 1997. Cytomegalovirus glycoprotein B sequence variation among Japanese bone marrow transplant recipients. Intervirology 40:215-219.
37. Woo PC, Lo CY, Lo SK, Siau H, Peiris JS, Wong SS, Luk WK, Chan TM, Lim WW, Yuen KY. 1997. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 4:515-518.
38. Zipeto D, Hong C, Gerna G, Zavattoni M, Katzenstein D, Merigan TC, Rasmussen L. 1998. Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retroviruses 14:533-536.